ClinicalTrials.Veeva

Menu
K

K.G. Hospital | Neurology Department

Research site
(Unclaimed)

Site insights

Top conditions

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke (OCEANIC-STROKE)

Researchers are looking for a better way to prevent an ischemic stroke which occurs when a blood clot travelled to the brain in people who within the...

Active, not recruiting
High-risk Transient Ischemic Attack
Acute Non-cardioembolic Ischemic Stroke
Drug: Asundexian (BAY2433334)
Drug: Placebo

Alport syndrome (AS) is a rare genetic condition that causes kidney disease, hearing loss, and eye abnormalities that occur due to changes in specifi...

Not yet enrolling
Alport Syndrome
Other: Placebo
Biological: BAY 3401016

Trial sponsors

Bayer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems